CCDC78
Basic information
Region (hg38): 16:722582-726954
Previous symbols: [ "C16orf25" ]
Links
Phenotypes
GenCC
Source:
- congenital myopathy with internal nuclei and atypical cores (Strong), mode of inheritance: AD
- congenital myopathy with internal nuclei and atypical cores (Supportive), mode of inheritance: AD
- congenital myopathy with internal nuclei and atypical cores (Limited), mode of inheritance: AD
- centronuclear myopathy (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Myopathy, centronuclear, 4 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal | 22818856 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCDC78 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 89 | 96 | ||||
missense | 204 | 34 | 240 | |||
nonsense | 15 | 18 | ||||
start loss | 1 | |||||
frameshift | 11 | 11 | ||||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 11 | 13 | ||||
splice region | 17 | 20 | 1 | 38 | ||
non coding | 78 | 24 | 109 | |||
Total | 0 | 0 | 256 | 206 | 30 |
Variants in CCDC78
This is a list of pathogenic ClinVar variants found in the CCDC78 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-722600-A-C | Benign (Aug 30, 2018) | |||
16-722645-A-AGCTCTGCTCT | Likely benign (Dec 19, 2019) | |||
16-722762-C-T | Likely benign (Sep 01, 2023) | |||
16-722768-C-T | not specified | Likely benign (-) | ||
16-722772-A-G | CCDC78-related disorder | Uncertain significance (Mar 09, 2023) | ||
16-722779-C-T | Congenital myopathy with internal nuclei and atypical cores | Likely benign (Apr 06, 2023) | ||
16-722780-G-A | Congenital myopathy with internal nuclei and atypical cores | Uncertain significance (Jan 02, 2024) | ||
16-722780-G-C | Congenital myopathy with internal nuclei and atypical cores • Inborn genetic diseases | Conflicting classifications of pathogenicity (Mar 30, 2024) | ||
16-722783-C-T | Congenital myopathy with internal nuclei and atypical cores | Uncertain significance (Jan 13, 2023) | ||
16-722784-T-C | Congenital myopathy with internal nuclei and atypical cores | Uncertain significance (Jun 04, 2023) | ||
16-722790-C-G | Congenital myopathy with internal nuclei and atypical cores | Uncertain significance (Jun 20, 2022) | ||
16-722797-G-T | Congenital myopathy with internal nuclei and atypical cores | Benign/Likely benign (Jan 05, 2024) | ||
16-722799-G-A | Congenital myopathy with internal nuclei and atypical cores | Likely benign (Sep 21, 2019) | ||
16-722808-C-A | Congenital myopathy with internal nuclei and atypical cores | Likely benign (May 19, 2021) | ||
16-722808-C-T | Congenital myopathy with internal nuclei and atypical cores | Likely benign (Mar 12, 2023) | ||
16-722842-T-C | Congenital myopathy with internal nuclei and atypical cores | Benign (Jul 14, 2021) | ||
16-722848-C-T | Benign (Jul 27, 2018) | |||
16-722867-C-T | Likely benign (Oct 27, 2018) | |||
16-722908-C-T | Congenital myopathy with internal nuclei and atypical cores | Likely benign (Jun 28, 2023) | ||
16-722912-C-T | Congenital myopathy with internal nuclei and atypical cores | Likely benign (Nov 07, 2023) | ||
16-722924-G-T | Congenital myopathy with internal nuclei and atypical cores | Uncertain significance (Aug 21, 2020) | ||
16-722925-C-T | Congenital myopathy with internal nuclei and atypical cores | Uncertain significance (Nov 02, 2022) | ||
16-722927-C-G | Inborn genetic diseases | Uncertain significance (Dec 15, 2023) | ||
16-722931-T-C | Congenital myopathy with internal nuclei and atypical cores | Uncertain significance (Feb 27, 2023) | ||
16-722935-G-A | Congenital myopathy with internal nuclei and atypical cores | Likely benign (Aug 02, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCDC78 | protein_coding | protein_coding | ENST00000293889 | 14 | 4373 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.97e-31 | 4.96e-7 | 124787 | 0 | 682 | 125469 | 0.00272 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.860 | 313 | 273 | 1.15 | 0.0000173 | 2779 |
Missense in Polyphen | 81 | 72.368 | 1.1193 | 852 | ||
Synonymous | -0.360 | 115 | 110 | 1.04 | 0.00000672 | 897 |
Loss of Function | -1.94 | 40 | 28.8 | 1.39 | 0.00000159 | 276 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00835 | 0.00812 |
Ashkenazi Jewish | 0.00140 | 0.00139 |
East Asian | 0.00149 | 0.00131 |
Finnish | 0.00944 | 0.00812 |
European (Non-Finnish) | 0.00213 | 0.00210 |
Middle Eastern | 0.00149 | 0.00131 |
South Asian | 0.000430 | 0.000425 |
Other | 0.00282 | 0.00278 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the deuterosome, a structure that promotes de novo centriole amplification in multiciliated cells that can generate more than 100 centrioles. Deuterosome-mediated centriole amplification occurs in terminally differentiated multiciliated cells (G1/0) and not in S phase. Essential for centriole amplification and is required for CEP152 localization to the deuterosome. {ECO:0000269|PubMed:24075808}.;
Intolerance Scores
- loftool
- 0.960
- rvis_EVS
- 1.42
- rvis_percentile_EVS
- 94.97
Haploinsufficiency Scores
- pHI
- 0.0832
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.406
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0620
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ccdc78
- Phenotype
Zebrafish Information Network
- Gene name
- ccdc78
- Affected structure
- skeletal muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- has extra parts of type
Gene ontology
- Biological process
- skeletal muscle contraction;cell projection organization;de novo centriole assembly involved in multi-ciliated epithelial cell differentiation
- Cellular component
- centriole;sarcoplasmic reticulum;sarcolemma;perinuclear region of cytoplasm;deuterosome
- Molecular function